|
The document outlines the environmental status and health monitoring related to C-8 (PFOA) exposure among employees, detailing findings of elevated organic fluorine levels in blood samples, the establishment of provisional acceptable exposure limits, and the lack of conclusive evidence of health problems associated with C-8 exposure, while also noting that DuPont was informed of potential birth defects linked to C-8 in animal studies
|
— |
AR226-2381
|
OzLxL724N1YOR82gBGrpO2egw |
14 |